Vikalp

Vikalp Group is an integrated global pharmaceutical and chemical conglomerate headquartered in Singapore, specializing in the contract manufacturing, sourcing, and distribution of active pharmaceutical ingredients (APIs), vaccines, and specialty chemical intermediates. The company's pharmaceutical division provides a broad range of essential building blocks and complex organic intermediates, such as isothiocyanates and piperazine derivatives, used in the synthesis of major therapeutic agents like enzalutamide and zonisamide. With a significant operational presence in Singapore, India, and Africa, Vikalp Group serves as a strategic partner to global generic pharmaceutical companies, offering cost-effective manufacturing solutions backed by integrated R&D and engineering capabilities. The group is also active in the distribution of vaccines and the production of bio-based fuels, positioning itself as a diversified player in the life sciences and energy sectors.